Multicentre, open label, randomised controlled trial comparing intermittent versus daily treatment for non-cavitary nodular/bronchiectatic Mycobacterium avium complex lung disease with rifampicin, ethambutol and clarithromycin (iREC): study protocol

Introduction Standard treatment for nodular/bronchiectatic Mycobacterium avium complex lung disease (NB MAC-LD), excluding severe-status cases, differs between Japan and other countries. Internationally, three-drug combination intermittent treatment (three times a week administration) with macrolide...

Descripció completa

Dades bibliogràfiques

Autors principals:	Akiko M Saito, Yoshikazu Inoue, Taku Nakagawa, Hiroya Hashimoto, Mitsuaki Yagi, Yoshihito Kogure, Masahiro Sekimizu, Kenji Ogawa
Format:	Artigo
Idioma:	Inglês
Publicat:	BMJ Publishing Group 2019-10-01
Col·lecció:	BMJ Open Respiratory Research
Accés en línia:	https://bmjopenrespres.bmj.com/content/6/1/e000434.full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!